The authors report a 27-year-old woman who presented with a large, choroidal melanoma when she was 28 weeks pregnant. Following detailed discussion with the patient, the decision was made to postpone any surgical treatment until after the birth of her child.
Methods
Case report.
Results
The patient had successful transscleral local resection of the tumor with 6/12 vision 6 months later. Cytogenetic studies showed a low risk of subsequent metastases.
Conclusions
This case illustrates that deferring the treatment of a choroidal melanoma presenting during pregnancy can be a reasonable treatment plan, if the patient is highly motivated to keep the eye.
ShieldsC.L., ShieldsJ.A., EagleR.C.Jr., De PotterP., MendukeH.Uveal melanoma and pregnancy. A report of 16 cases. Ophthalmology1991; 98: 1667–73.
2.
SeddonJ.M., MacLaughlinD.T., AlbertD.M., GragoudasE.S., FerenceM3rd. Uveal melanomas presenting during pregnancy and the investigation of oestrogen receptors in melanomas. Br J Ophthalmol1982; 66: 695–704.
3.
FossA.J., AlexanderR.A., GuilleM.J., HungerfordJ.L., McCartneyA.C., LightmanS.Estrogen and progesterone receptor analysis in ocular melanomas. Ophthalmology1995; 102: 431–5.
4.
EganK.M., QuinnJ.L., GragoudasE.S.Childbearing history associated with improved survival in choroidal melanoma. Arch Ophthalmol1999; 117: 939–42.
5.
DamatoB.Developments in the management of uveal melanoma. Clin Exp Ophthalmol2004; 32: 639–47.
6.
HorsmanD.E., WhiteV.A.Cytogenetic analysis of uveal melanoma. Consistent occurrence of monosomy 3 and trisomy 8q. Cancer1993; 71: 811–9.
7.
BaggettoL.G., GambrelleJ., DayanG.Major cytogenetic aberrations and typical multidrug resistance phenotype of uveal melanoma: current views and new therapeutic prospects. Cancer Treat Rev2005; 31: 361–79.
8.
ManshotW.A., Van StrikR.Is irradiation a justifiable treatment of choroidal melanoma? Analysis of published results. Br J Ophthalmol1987; 71: 348–52.
9.
AugsburgerJ.J., GonderJ.R., AmselJ., ShieldsJ.A., DonosoL.A.Growth rates and doubling times of posterior uveal melanomas. Ophthalmology1984; 91: 1709–15.
10.
BrandbergY., KockE., OskarK., af TrampeE., SeregardS.Psychological reactions and quality of life in patients with posterior uveal melanoma treated with ruthenium plaque therapy or enucleation: a one year follow-up study. Eye2000; 14(Pt 6): 839–46.
11.
CruickshanksK.J., FrybackD.G., NondalD.M.Treatment choice and quality of life in patients with choroidal melanoma. Arch Ophthalmol1999; 117: 461–7.
12.
DamatoB.Disease and ‘dis-ease’ in patients with uveal melanoma (editorial). Br J Ophthalmol2000; 84: 343–5.
